Article
Liquid Biopsy Testing for the Management of Patient with Non-Small Cell Lung Cancer Carrying a Rare Exon-20 EGFR Insertion.
The oncologist - 3 Feb 2022
Morabito Alessandro, Manzo Anna, Montanino Agnese, Rachiglio Anna Maria, Sforza Vincenzo, Pasquale Raffaella, Costanzo Raffaele, Maiello Monica R, Sandomenico Claudia, Gallo Marianna, Palumbo Giuliano, De Luca Antonella, La Rocca Antonello, Martucci Nicola, De Cecio Rossella, Picone Carmine, Lastoria Secondo, Normanno Nicola
Abstract excerpt
Increasing evidence suggests that liquid biopsy might play a relevant role in the management of metastatic non-small cell lung cancer (NSCLC) patients. Here, we show how the Molecular Tumor Board (MTB) in our cancer center employed liquid biopsy to support therapeutic decisions in a patient with NSCLC carrying a rare EGFR mutation. A 44-year-old woman, never-smoker with an EGFR, ALK, and ROS1-negative lung...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.